 |
|
|
| |
Long-Acting Lenacapavir in People With Multidrug-Resistant HIV-1: Week 52 Results
|
| |
| |
CROI 2022 Fe 14-16
Onyema Ogbuagu,1 Sorana Segal-Maurer,2 Cynthia Brinson,3 Ploenchan Chetchotisakd,4 Kenneth Lichtenstein,5 Joseph McGowan,6 Andrew A. Wiznia,7 Kimberly Workowski,8 Hui Wang,9 Nicolas Margot,9 Hadas Dvory-Sobol,9 Martin S. Rhee,9 Jared M. Baeten,9 Jean-Michel Molina10
1Yale University, New Haven, CT; 2New York Presbyterian-Queens, NY; 3Central Texas Clinical Research, Austin, TX; 4Srinagarind Hospital, Khon Kaen, Thailand; 5Eisenhower Health Center, Palm Springs, CA; 6Northwell Health, Manhasset, NY; 7Jacobi Medical Center, Bronx, NY; 8Emory University, Atlanta, GA; 9Gilead Sciences, Inc., Foster City, CA; 10Hôpital Saint Louis, Paris, France
|
| |
|
|
|
|
|
